Position in ENTA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$805,843
+$725,543 QoQ
Shares Held
63,804
+1153.0% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. ENTA ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ENTA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $805,843 | 63,804 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $80,300 | 5,092 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $183,223 | 15,307 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $363,167 | 48,038 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $254,736 | 46,148 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $179,123 | 31,152 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $303,920 | 29,336 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $125,744 | 9,695 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $354,699 | 20,315 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $199,773 | 21,230 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $144,739 | 12,958 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $930,792 | 43,495 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $417,016 | 10,312 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,768,503 | 38,016 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $112,972 | 2,178 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $575,700 | 12,179 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,801,138 | 25,304 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,018,419 | 40,364 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,772,756 | 31,205 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $484,726 | 11,014 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,293,663 | 26,230 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,957 | 94 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $22,895 | 456 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $252,160 | 4,903 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||